124 related articles for article (PubMed ID: 22101583)
1. Case of the month. The uncontrollable shaking arm.
Schraml FV; Karis J; Mullen BR
Br J Radiol; 2011 Dec; 84(1008):1153-5. PubMed ID: 22101583
[No Abstract] [Full Text] [Related]
2. How reliable is
Ciarmiello A
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2180-2182. PubMed ID: 27511187
[No Abstract] [Full Text] [Related]
3. Contralateral cortical diaschisis in a patient with cerebellar astrocytoma after radiation therapy.
Newberg AB; Alavi A; Alavi J
Clin Nucl Med; 2000 Jun; 25(6):431-3. PubMed ID: 10836690
[TBL] [Abstract][Full Text] [Related]
4. F-18 FDG PET in spinal cord pilocytic astrocytoma.
Wu PS; Yao WJ
Clin Nucl Med; 2010 Aug; 35(8):649-50. PubMed ID: 20631528
[No Abstract] [Full Text] [Related]
5. Reversible striatal hypermetabolism in a case of rare adult-onset Sydenham chorea on two sequential 18F-FDG PET studies.
Paghera B; Caobelli F; Giubbini R; Premi E; Padovani A
J Neuroradiol; 2011 Dec; 38(5):325-6. PubMed ID: 21215457
[No Abstract] [Full Text] [Related]
6. Brain Metabolism of Less-Educated Patients With Alzheimer Dementia Studied by Positron Emission Tomography.
Huang YC; Yen PS; Wu ST; Chen JT; Hung GU; Kao CH; Chen TY; Ho FM
Medicine (Baltimore); 2015 Jul; 94(30):e1252. PubMed ID: 26222866
[TBL] [Abstract][Full Text] [Related]
7. Crossed cerebellar hyperperfusion on ictal FDG PET in astrocytoma.
Lin M; Smith T; Beran RG
J Clin Neurosci; 2009 Apr; 16(4):603-4. PubMed ID: 19231196
[TBL] [Abstract][Full Text] [Related]
8. Advantage of late scanning in brain 18F-FDG PET.
Ishii K
J Nucl Med; 2006 Apr; 47(4):729; author reply 729. PubMed ID: 16595511
[No Abstract] [Full Text] [Related]
9. Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy.
Peter J; Houshmand S; Werner TJ; Rubello D; Alavi A
Nucl Med Commun; 2016 Aug; 37(8):882-7. PubMed ID: 27092666
[TBL] [Abstract][Full Text] [Related]
10. Behavioral correlates of posteromedial parietal cortex hypometabolism in a family with idiopathic basal ganglia calcifications.
Cavanna AE; Trimble MR
J Neurol Sci; 2008 Mar; 266(1-2):190-1. PubMed ID: 17942119
[No Abstract] [Full Text] [Related]
11. On the multivariate nature of brain metabolic impairment in Alzheimer's disease.
Salmon E; Kerrouche N; Perani D; Lekeu F; Holthoff V; Beuthien-Baumann B; Sorbi S; Lemaire C; Collette F; Herholz K
Neurobiol Aging; 2009 Feb; 30(2):186-97. PubMed ID: 17651869
[TBL] [Abstract][Full Text] [Related]
12. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of recurrent astrocytoma with fludeoxyglucose F18 PET scanning.
Mirzaei S; Knoll P; Kohn H
N Engl J Med; 2001 Jun; 344(26):2030-1. PubMed ID: 11430342
[No Abstract] [Full Text] [Related]
14. [Clinical application of positron emission tomography and 18FDG to brain tumor].
Momose T
Nihon Rinsho; 2005 Sep; 63 Suppl 9():242-9. PubMed ID: 16201530
[No Abstract] [Full Text] [Related]
15. Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with.
Tsuyuguchi N; Matsuoka Y; Sunada I; Matsusaka Y; Haque M
AJNR Am J Neuroradiol; 2001 Feb; 22(2):311-3. PubMed ID: 11156775
[TBL] [Abstract][Full Text] [Related]
16. Hyperventilation-induced limb shaking TIA in Moyamoya disease.
Kim HY; Chung CS; Lee J; Han DH; Lee KH
Neurology; 2003 Jan; 60(1):137-9. PubMed ID: 12525739
[TBL] [Abstract][Full Text] [Related]
17. Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis.
Matías-Guiu JA; Pytel V; Cabrera-Martín MN; Galán L; Valles-Salgado M; Guerrero A; Moreno-Ramos T; Matías-Guiu J; Carreras JL
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2050-60. PubMed ID: 27262702
[TBL] [Abstract][Full Text] [Related]
18. Brain metabolic alterations herald falls in patients with Parkinson's disease.
Isaias IU; Brumberg J; Pozzi NG; Palmisano C; Canessa A; Marotta G; Volkmann J; Pezzoli G
Ann Clin Transl Neurol; 2020 Apr; 7(4):579-583. PubMed ID: 32162447
[TBL] [Abstract][Full Text] [Related]
19. Cerebral metabolic changes associated with Lyme disease.
Newberg A; Hassan A; Alavi A
Nucl Med Commun; 2002 Aug; 23(8):773-7. PubMed ID: 12124483
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the new consensus criteria for the diagnosis of primary progressive aphasia using fluorodeoxyglucose positron emission tomography.
Matias-Guiu JA; Cabrera-Martín MN; García-Ramos R; Moreno-Ramos T; Valles-Salgado M; Carreras JL; Matias-Guiu J
Dement Geriatr Cogn Disord; 2014; 38(3-4):147-52. PubMed ID: 24732287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]